Brief: Titan Pharmaceuticals Inc-On Jan 4, 2023 Received Notice Of Delisting Or Failure To Satisfy Continued Listing Transfer Of Listing From Nasdaq
06/01/2023 21:20
Jan 6 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS INC-ON JAN 4, 2023 RECEIVED NOTICE
OF
DELISTING OR FAILURE TO SATISFY CONTINUED LISTING; TRANSFER OF
LISTING FROM NASDAQ
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.